Huang Yan, Bao Ting, Li Zhenzhen, Ji Guiyi, Zhang Li
Health Management Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Laboratory of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Oncol Lett. 2020 Aug;20(2):1256-1262. doi: 10.3892/ol.2020.11649. Epub 2020 May 20.
Lung cancer is the most prevalent type of cancer worldwide and is the leading cause of cancer-associated cases of mortality in the USA and China. Non-small cell lung cancer (NSCLC) accounts for 80-85% of lung cancer cases. microRNAs (miRs) serve multiple roles in the pathogenesis of lung cancer. The current study investigated the lower level of miR-200a in tumor tissues compared with healthy tissue. Overexpression of miR-200a inhibited NSCLC cell proliferation and promoted apoptosis. miR-200a was identified to target Rhophilin Rho GTPase binding protein 2 (RHPN2) and higher levels of RHPN2 were observed in tumor tissues compared with adjacent normal tissues. The current study proposes that miR-200a exhibits a tumor suppressive role in NSCLC and suggests that miR-200a could target RHPN2.
肺癌是全球最常见的癌症类型,也是美国和中国癌症相关死亡病例的主要原因。非小细胞肺癌(NSCLC)占肺癌病例的80-85%。微小RNA(miRs)在肺癌发病机制中发挥多种作用。当前研究调查了与健康组织相比,肿瘤组织中miR-200a水平较低的情况。miR-200a的过表达抑制了NSCLC细胞增殖并促进了细胞凋亡。已确定miR-200a靶向Rho相关蛋白2(RHPN2),并且与相邻正常组织相比,在肿瘤组织中观察到更高水平的RHPN2。当前研究提出miR-200a在NSCLC中发挥肿瘤抑制作用,并表明miR-200a可能靶向RHPN2。